

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.13096233 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 5.13096233 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.93328678 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 4.93328678 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 4.33787179 |
| 6 | sulfur amino acid catabolic process (GO:0000098) | 4.28727932 |
| 7 | alpha-linolenic acid metabolic process (GO:0036109) | 4.28652234 |
| 8 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.23698378 |
| 9 | complement activation, alternative pathway (GO:0006957) | 4.13898443 |
| 10 | protein carboxylation (GO:0018214) | 4.12395774 |
| 11 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.12395774 |
| 12 | cysteine metabolic process (GO:0006534) | 4.01261859 |
| 13 | barbed-end actin filament capping (GO:0051016) | 3.89814147 |
| 14 | high-density lipoprotein particle remodeling (GO:0034375) | 3.85596187 |
| 15 | urea cycle (GO:0000050) | 3.85466789 |
| 16 | urea metabolic process (GO:0019627) | 3.85466789 |
| 17 | intestinal cholesterol absorption (GO:0030299) | 3.82184770 |
| 18 | bile acid biosynthetic process (GO:0006699) | 3.81123743 |
| 19 | kynurenine metabolic process (GO:0070189) | 3.77432341 |
| 20 | regulation of cholesterol homeostasis (GO:2000188) | 3.75786060 |
| 21 | regulation of protein activation cascade (GO:2000257) | 3.74942853 |
| 22 | negative regulation of fibrinolysis (GO:0051918) | 3.74134017 |
| 23 | glyoxylate metabolic process (GO:0046487) | 3.72820993 |
| 24 | protein localization to endosome (GO:0036010) | 3.70151107 |
| 25 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.69371937 |
| 26 | tryptophan catabolic process (GO:0006569) | 3.67813778 |
| 27 | indole-containing compound catabolic process (GO:0042436) | 3.67813778 |
| 28 | indolalkylamine catabolic process (GO:0046218) | 3.67813778 |
| 29 | reverse cholesterol transport (GO:0043691) | 3.65006047 |
| 30 | Golgi transport vesicle coating (GO:0048200) | 3.63600990 |
| 31 | COPI coating of Golgi vesicle (GO:0048205) | 3.63600990 |
| 32 | negative regulation of sterol transport (GO:0032372) | 3.62700411 |
| 33 | negative regulation of cholesterol transport (GO:0032375) | 3.62700411 |
| 34 | lysine catabolic process (GO:0006554) | 3.61040021 |
| 35 | lysine metabolic process (GO:0006553) | 3.61040021 |
| 36 | regulation of complement activation (GO:0030449) | 3.59069462 |
| 37 | cellular modified amino acid catabolic process (GO:0042219) | 3.56848118 |
| 38 | tryptophan metabolic process (GO:0006568) | 3.55905304 |
| 39 | nitrogen cycle metabolic process (GO:0071941) | 3.49353974 |
| 40 | homocysteine metabolic process (GO:0050667) | 3.46606015 |
| 41 | regulation of triglyceride catabolic process (GO:0010896) | 3.45092974 |
| 42 | regulation of fibrinolysis (GO:0051917) | 3.42007564 |
| 43 | phospholipid efflux (GO:0033700) | 3.41017661 |
| 44 | bile acid metabolic process (GO:0008206) | 3.38710275 |
| 45 | plasma lipoprotein particle remodeling (GO:0034369) | 3.31247522 |
| 46 | protein-lipid complex remodeling (GO:0034368) | 3.31247522 |
| 47 | macromolecular complex remodeling (GO:0034367) | 3.31247522 |
| 48 | plasma lipoprotein particle clearance (GO:0034381) | 3.27605758 |
| 49 | valine metabolic process (GO:0006573) | 3.25481351 |
| 50 | skin morphogenesis (GO:0043589) | 3.19679870 |
| 51 | cholesterol efflux (GO:0033344) | 3.17999272 |
| 52 | acylglycerol homeostasis (GO:0055090) | 3.11872645 |
| 53 | triglyceride homeostasis (GO:0070328) | 3.11872645 |
| 54 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.11866124 |
| 55 | glycosphingolipid catabolic process (GO:0046479) | 3.11187838 |
| 56 | regulation of cholesterol esterification (GO:0010872) | 3.10708344 |
| 57 | pinocytosis (GO:0006907) | 3.10334479 |
| 58 | tyrosine metabolic process (GO:0006570) | 3.09612638 |
| 59 | cellular ketone body metabolic process (GO:0046950) | 3.09587746 |
| 60 | aromatic amino acid family metabolic process (GO:0009072) | 3.09565438 |
| 61 | response to peptidoglycan (GO:0032494) | 3.09024702 |
| 62 | glutamate metabolic process (GO:0006536) | 3.07796794 |
| 63 | bile acid and bile salt transport (GO:0015721) | 3.07357640 |
| 64 | ethanol oxidation (GO:0006069) | 3.03988605 |
| 65 | amino-acid betaine metabolic process (GO:0006577) | 3.03585776 |
| 66 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.02863186 |
| 67 | serine family amino acid catabolic process (GO:0009071) | 2.97465363 |
| 68 | alpha-amino acid catabolic process (GO:1901606) | 2.97191623 |
| 69 | plasma lipoprotein particle assembly (GO:0034377) | 2.96532690 |
| 70 | phospholipid homeostasis (GO:0055091) | 2.96164899 |
| 71 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.96124445 |
| 72 | drug catabolic process (GO:0042737) | 2.95895564 |
| 73 | drug transmembrane transport (GO:0006855) | 2.92923059 |
| 74 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.91974808 |
| 75 | cellular amino acid catabolic process (GO:0009063) | 2.90750039 |
| 76 | coenzyme catabolic process (GO:0009109) | 2.90451067 |
| 77 | * maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.89632423 |
| 78 | 4-hydroxyproline metabolic process (GO:0019471) | 2.89100183 |
| 79 | protein-lipid complex assembly (GO:0065005) | 2.88907291 |
| 80 | positive regulation of lipid catabolic process (GO:0050996) | 2.88788748 |
| 81 | regulation of extracellular matrix disassembly (GO:0010715) | 2.86704091 |
| 82 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.86097855 |
| 83 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.86097855 |
| 84 | short-chain fatty acid metabolic process (GO:0046459) | 2.85961768 |
| 85 | 2-oxoglutarate metabolic process (GO:0006103) | 2.85498448 |
| 86 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.85264170 |
| 87 | complement activation, classical pathway (GO:0006958) | 2.84581161 |
| 88 | complement activation (GO:0006956) | 2.84423003 |
| 89 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.82553553 |
| 90 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.82335964 |
| 91 | glycolipid catabolic process (GO:0019377) | 2.80533881 |
| 92 | peptide catabolic process (GO:0043171) | 2.79249004 |
| 93 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.78985948 |
| 94 | lipoprotein metabolic process (GO:0042157) | 2.78614850 |
| 95 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.76600014 |
| 96 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.76263792 |
| 97 | cholesterol homeostasis (GO:0042632) | 2.76218616 |
| 98 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.76215107 |
| 99 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.75994017 |
| 100 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.75994017 |
| 101 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.75111023 |
| 102 | sterol homeostasis (GO:0055092) | 2.74951733 |
| 103 | transcytosis (GO:0045056) | 2.74425180 |
| 104 | apoptotic cell clearance (GO:0043277) | 2.73981632 |
| 105 | plasma lipoprotein particle organization (GO:0071827) | 2.72282365 |
| 106 | intestinal absorption (GO:0050892) | 2.71936511 |
| 107 | detection of other organism (GO:0098543) | 2.71589186 |
| 108 | indolalkylamine metabolic process (GO:0006586) | 2.70364197 |
| 109 | benzene-containing compound metabolic process (GO:0042537) | 2.70052337 |
| 110 | protein-lipid complex subunit organization (GO:0071825) | 2.69419251 |
| 111 | fibrinolysis (GO:0042730) | 2.67969589 |
| 112 | ketone body metabolic process (GO:1902224) | 2.66864351 |
| 113 | basement membrane organization (GO:0071711) | 2.66351145 |
| 114 | cytolysis (GO:0019835) | 2.66224998 |
| 115 | fatty acid oxidation (GO:0019395) | 2.65484098 |
| 116 | detection of molecule of bacterial origin (GO:0032490) | 2.65038008 |
| 117 | regulation of leukocyte degranulation (GO:0043300) | 2.63570601 |
| 118 | positive regulation by symbiont of host defense response (GO:0052509) | 2.63168998 |
| 119 | modulation by symbiont of host defense response (GO:0052031) | 2.63168998 |
| 120 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.63168998 |
| 121 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.63168998 |
| 122 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.63168998 |
| 123 | modulation by symbiont of host immune response (GO:0052553) | 2.63168998 |
| 124 | mannose metabolic process (GO:0006013) | 2.63053879 |
| 125 | * protein retention in ER lumen (GO:0006621) | 2.62135850 |
| 126 | acute-phase response (GO:0006953) | 2.62069475 |
| 127 | cholesterol transport (GO:0030301) | 2.61761588 |
| 128 | response to laminar fluid shear stress (GO:0034616) | 2.60759110 |
| 129 | detection of bacterium (GO:0016045) | 2.60042379 |
| 130 | macrophage activation involved in immune response (GO:0002281) | 2.60011754 |
| 131 | negative regulation of cell killing (GO:0031342) | 2.59870418 |
| 132 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.59870418 |
| 133 | positive regulation of extracellular matrix organization (GO:1903055) | 2.58728846 |
| 134 | detection of external biotic stimulus (GO:0098581) | 2.58038263 |
| 135 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.56492240 |
| 136 | response to muramyl dipeptide (GO:0032495) | 2.55015084 |
| 137 | stress fiber assembly (GO:0043149) | 2.54731848 |
| 138 | adhesion of symbiont to host (GO:0044406) | 2.54453975 |
| 139 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.52258847 |
| 140 | low-density lipoprotein particle clearance (GO:0034383) | 2.49141228 |
| 141 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.48567588 |
| 142 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.48487327 |
| 143 | amyloid precursor protein catabolic process (GO:0042987) | 2.47455335 |
| 144 | oligosaccharide catabolic process (GO:0009313) | 2.44754750 |
| 145 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.43766019 |
| 146 | positive regulation of receptor recycling (GO:0001921) | 2.42624323 |
| 147 | response to thyroid hormone (GO:0097066) | 2.42400285 |
| 148 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.40046473 |
| 149 | surfactant homeostasis (GO:0043129) | 2.38999666 |
| 150 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.38034475 |
| 151 | adhesion of symbiont to host cell (GO:0044650) | 2.36534826 |
| 152 | virion attachment to host cell (GO:0019062) | 2.36534826 |
| 153 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.34510899 |
| 154 | hyaluronan catabolic process (GO:0030214) | 2.32783148 |
| 155 | cell adhesion mediated by integrin (GO:0033627) | 2.31953979 |
| 156 | fibril organization (GO:0097435) | 2.30967931 |
| 157 | positive regulation of leukocyte degranulation (GO:0043302) | 2.30797380 |
| 158 | regulation of early endosome to late endosome transport (GO:2000641) | 2.30721854 |
| 159 | positive regulation of phagocytosis (GO:0050766) | 2.30672625 |
| 160 | amino sugar catabolic process (GO:0046348) | 2.30608045 |
| 161 | positive regulation of nuclease activity (GO:0032075) | 2.30504087 |
| 162 | neutrophil activation involved in immune response (GO:0002283) | 2.29996486 |
| 163 | regulation of extracellular matrix organization (GO:1903053) | 2.29547223 |
| 164 | regulation of mast cell degranulation (GO:0043304) | 2.29272220 |
| 165 | ceramide catabolic process (GO:0046514) | 2.29030974 |
| 166 | detection of biotic stimulus (GO:0009595) | 2.24946277 |
| 167 | regulation of apoptotic cell clearance (GO:2000425) | 2.22962946 |
| 168 | keratan sulfate catabolic process (GO:0042340) | 2.21923297 |
| 169 | hypotonic response (GO:0006971) | 2.20576093 |
| 170 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.19260360 |
| 171 | membrane protein ectodomain proteolysis (GO:0006509) | 2.18681865 |
| 172 | negative regulation of interleukin-12 production (GO:0032695) | 2.18257544 |
| 173 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.18128280 |
| 174 | glial cell migration (GO:0008347) | 2.18064499 |
| 175 | cortical actin cytoskeleton organization (GO:0030866) | 2.17287168 |
| 176 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.16142058 |
| 177 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.14731637 |
| 178 | regulation of superoxide anion generation (GO:0032928) | 2.13388943 |
| 179 | negative regulation of type 2 immune response (GO:0002829) | 2.12155473 |
| 180 | glucose 6-phosphate metabolic process (GO:0051156) | 2.10350507 |
| 181 | embryo implantation (GO:0007566) | 2.10268753 |
| 182 | modulation by symbiont of host cellular process (GO:0044068) | 2.10054886 |
| 183 | endodermal cell differentiation (GO:0035987) | 2.10044948 |
| 184 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.08645643 |
| 185 | semaphorin-plexin signaling pathway (GO:0071526) | 2.07550865 |
| 186 | pentose-phosphate shunt (GO:0006098) | 2.06952345 |
| 187 | NIK/NF-kappaB signaling (GO:0038061) | 2.06705585 |
| 188 | cellular copper ion homeostasis (GO:0006878) | 2.06038490 |
| 189 | ER-nucleus signaling pathway (GO:0006984) | 2.06029433 |
| 190 | regulation of nuclease activity (GO:0032069) | 2.05659542 |
| 191 | regulation of cholesterol storage (GO:0010885) | 2.05272345 |
| 192 | angiotensin maturation (GO:0002003) | 2.04638850 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 7.13151426 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.24547372 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.61642572 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.27159362 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.53836320 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.26045035 |
| 7 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.97921037 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.78863616 |
| 9 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.44163238 |
| 10 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.42560074 |
| 11 | * CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.33754817 |
| 12 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.17555124 |
| 13 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.96363295 |
| 14 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.80818460 |
| 15 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.77846101 |
| 16 | GATA1_22025678_ChIP-Seq_K562_Human | 1.73845771 |
| 17 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.71701299 |
| 18 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.66961353 |
| 19 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.64627940 |
| 20 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.64382066 |
| 21 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.63993193 |
| 22 | MYC_22102868_ChIP-Seq_BL_Human | 1.63117877 |
| 23 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.62726826 |
| 24 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.61271285 |
| 25 | * CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.58125736 |
| 26 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.55728518 |
| 27 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.55704766 |
| 28 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.52447718 |
| 29 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.51678427 |
| 30 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.51462829 |
| 31 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.48162915 |
| 32 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.44693200 |
| 33 | SPI1_23127762_ChIP-Seq_K562_Human | 1.42522685 |
| 34 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.42127018 |
| 35 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.39410206 |
| 36 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.39311434 |
| 37 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.38141937 |
| 38 | MAF_26560356_Chip-Seq_TH1_Human | 1.34614937 |
| 39 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.33456702 |
| 40 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.29371875 |
| 41 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.28954962 |
| 42 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.28418325 |
| 43 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.27089954 |
| 44 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.26115749 |
| 45 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.25167107 |
| 46 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.23517265 |
| 47 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.23335430 |
| 48 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.23097942 |
| 49 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.23018715 |
| 50 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.22537146 |
| 51 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.21128734 |
| 52 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.20789615 |
| 53 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.19565692 |
| 54 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.18142693 |
| 55 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.18079040 |
| 56 | UTX_26944678_Chip-Seq_JUKART_Human | 1.17720281 |
| 57 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.17693207 |
| 58 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.17423254 |
| 59 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.16154179 |
| 60 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.14874029 |
| 61 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.14236331 |
| 62 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.13458236 |
| 63 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.13115814 |
| 64 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.12542955 |
| 65 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.12358012 |
| 66 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.12134857 |
| 67 | GATA1_19941826_ChIP-Seq_K562_Human | 1.11608688 |
| 68 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.11424780 |
| 69 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.11158785 |
| 70 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.10621680 |
| 71 | ATF3_27146783_Chip-Seq_COLON_Human | 1.09063589 |
| 72 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.07812468 |
| 73 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.07617858 |
| 74 | MAF_26560356_Chip-Seq_TH2_Human | 1.06621496 |
| 75 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.06416681 |
| 76 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.06085894 |
| 77 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.05941296 |
| 78 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.05934685 |
| 79 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.05153564 |
| 80 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.04980415 |
| 81 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.04741940 |
| 82 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.04170449 |
| 83 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.03706310 |
| 84 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.03417169 |
| 85 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.01828185 |
| 86 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.01314481 |
| 87 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.00607972 |
| 88 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.00420591 |
| 89 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.00207628 |
| 90 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.99401870 |
| 91 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.99322802 |
| 92 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.99010081 |
| 93 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.98592058 |
| 94 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.98344053 |
| 95 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.98151575 |
| 96 | * SPI1_23547873_ChIP-Seq_NB4_Human | 0.97500532 |
| 97 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.97482056 |
| 98 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.97129194 |
| 99 | GATA2_19941826_ChIP-Seq_K562_Human | 0.96882809 |
| 100 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.96828557 |
| 101 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.95828099 |
| 102 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.95605858 |
| 103 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.95095759 |
| 104 | KDM2B_26808549_Chip-Seq_K562_Human | 0.93795280 |
| 105 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.93586246 |
| 106 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.93078176 |
| 107 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.92065692 |
| 108 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.90424705 |
| 109 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.90262954 |
| 110 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.89315277 |
| 111 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.89131164 |
| 112 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.87301191 |
| 113 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.87286454 |
| 114 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.86935707 |
| 115 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.86261888 |
| 116 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.85344751 |
| 117 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.84481937 |
| 118 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.83405485 |
| 119 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.83405485 |
| 120 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.83057645 |
| 121 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.82139018 |
| 122 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.81164467 |
| 123 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.81148294 |
| 124 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.80104823 |
| 125 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.79869330 |
| 126 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.79759145 |
| 127 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.79565428 |
| 128 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.79349451 |
| 129 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.79256216 |
| 130 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.78824128 |
| 131 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.77987906 |
| 132 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.77693729 |
| 133 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.77466016 |
| 134 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.77420754 |
| 135 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.76652489 |
| 136 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.75255011 |
| 137 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.74573356 |
| 138 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.74573356 |
| 139 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.73276445 |
| 140 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.73106149 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 5.87314343 |
| 2 | MP0005360_urolithiasis | 5.36006706 |
| 3 | MP0005365_abnormal_bile_salt | 4.73970864 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 4.29119001 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 3.64284277 |
| 6 | MP0003252_abnormal_bile_duct | 3.20118196 |
| 7 | MP0009840_abnormal_foam_cell | 3.01491993 |
| 8 | MP0001666_abnormal_nutrient_absorption | 2.99025559 |
| 9 | MP0005083_abnormal_biliary_tract | 2.96703303 |
| 10 | MP0010329_abnormal_lipoprotein_level | 2.87086989 |
| 11 | MP0003191_abnormal_cellular_cholesterol | 2.67391308 |
| 12 | MP0003195_calcinosis | 2.31805471 |
| 13 | MP0003300_gastrointestinal_ulcer | 2.27859938 |
| 14 | MP0005332_abnormal_amino_acid | 2.12335367 |
| 15 | MP0005058_abnormal_lysosome_morphology | 2.11136960 |
| 16 | MP0003705_abnormal_hypodermis_morpholog | 2.08235953 |
| 17 | MP0004858_abnormal_nervous_system | 1.99278913 |
| 18 | MP0002138_abnormal_hepatobiliary_system | 1.94299652 |
| 19 | MP0002118_abnormal_lipid_homeostasis | 1.88980203 |
| 20 | MP0000609_abnormal_liver_physiology | 1.84912022 |
| 21 | MP0000858_altered_metastatic_potential | 1.83586635 |
| 22 | MP0003868_abnormal_feces_composition | 1.82885867 |
| 23 | MP0005257_abnormal_intraocular_pressure | 1.81684946 |
| 24 | MP0010234_abnormal_vibrissa_follicle | 1.77091667 |
| 25 | MP0001958_emphysema | 1.74818349 |
| 26 | MP0008260_abnormal_autophagy | 1.74276689 |
| 27 | MP0002998_abnormal_bone_remodeling | 1.73020199 |
| 28 | MP0009643_abnormal_urine_homeostasis | 1.67313230 |
| 29 | MP0005220_abnormal_exocrine_pancreas | 1.64625508 |
| 30 | MP0005025_abnormal_response_to | 1.61918408 |
| 31 | MP0004019_abnormal_vitamin_homeostasis | 1.61576232 |
| 32 | MP0002909_abnormal_adrenal_gland | 1.61522437 |
| 33 | MP0003091_abnormal_cell_migration | 1.60810591 |
| 34 | MP0003279_aneurysm | 1.59224709 |
| 35 | MP0001835_abnormal_antigen_presentation | 1.57778375 |
| 36 | MP0000604_amyloidosis | 1.56511677 |
| 37 | MP0004272_abnormal_basement_membrane | 1.55917861 |
| 38 | MP0003806_abnormal_nucleotide_metabolis | 1.55906551 |
| 39 | MP0009785_altered_susceptibility_to | 1.53789782 |
| 40 | MP0001849_ear_inflammation | 1.49323661 |
| 41 | MP0005076_abnormal_cell_differentiation | 1.48711744 |
| 42 | MP0000343_altered_response_to | 1.45911523 |
| 43 | MP0005000_abnormal_immune_tolerance | 1.45084784 |
| 44 | MP0005319_abnormal_enzyme/_coenzyme | 1.44614145 |
| 45 | MP0009278_abnormal_bone_marrow | 1.43752333 |
| 46 | MP0003453_abnormal_keratinocyte_physiol | 1.43516921 |
| 47 | MP0002148_abnormal_hypersensitivity_rea | 1.41053097 |
| 48 | MP0005164_abnormal_response_to | 1.40661202 |
| 49 | MP0005409_darkened_coat_color | 1.38983980 |
| 50 | MP0003448_altered_tumor_morphology | 1.38875495 |
| 51 | MP0003172_abnormal_lysosome_physiology | 1.37953433 |
| 52 | MP0009780_abnormal_chondrocyte_physiolo | 1.37033565 |
| 53 | MP0005387_immune_system_phenotype | 1.29896391 |
| 54 | MP0005023_abnormal_wound_healing | 1.29621207 |
| 55 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.29609646 |
| 56 | MP0003283_abnormal_digestive_organ | 1.28410089 |
| 57 | MP0008438_abnormal_cutaneous_collagen | 1.27559804 |
| 58 | MP0005275_abnormal_skin_tensile | 1.26779134 |
| 59 | MP0010155_abnormal_intestine_physiology | 1.26279352 |
| 60 | MP0003828_pulmonary_edema | 1.25727079 |
| 61 | MP0003183_abnormal_peptide_metabolism | 1.25589315 |
| 62 | MP0003329_amyloid_beta_deposits | 1.21685772 |
| 63 | MP0003303_peritoneal_inflammation | 1.20375298 |
| 64 | MP0008961_abnormal_basal_metabolism | 1.17594050 |
| 65 | MP0004510_myositis | 1.17285104 |
| 66 | MP0004043_abnormal_pH_regulation | 1.16606159 |
| 67 | MP0001756_abnormal_urination | 1.13915912 |
| 68 | MP0001944_abnormal_pancreas_morphology | 1.12098253 |
| 69 | MP0002078_abnormal_glucose_homeostasis | 1.12060223 |
| 70 | MP0001765_abnormal_ion_homeostasis | 1.11135639 |
| 71 | MP0005390_skeleton_phenotype | 1.10460400 |
| 72 | MP0001542_abnormal_bone_strength | 1.10439219 |
| 73 | MP0002452_abnormal_antigen_presenting | 1.09626580 |
| 74 | MP0003075_altered_response_to | 1.08881728 |
| 75 | MP0003656_abnormal_erythrocyte_physiolo | 1.07978715 |
| 76 | MP0002060_abnormal_skin_morphology | 1.07475003 |
| 77 | MP0004782_abnormal_surfactant_physiolog | 1.06912202 |
| 78 | MP0002723_abnormal_immune_serum | 1.05592270 |
| 79 | MP0002254_reproductive_system_inflammat | 1.05561637 |
| 80 | MP0002877_abnormal_melanocyte_morpholog | 1.05408752 |
| 81 | MP0003436_decreased_susceptibility_to | 1.05101733 |
| 82 | MP0005636_abnormal_mineral_homeostasis | 1.05021442 |
| 83 | MP0004130_abnormal_muscle_cell | 1.02200050 |
| 84 | MP0002693_abnormal_pancreas_physiology | 0.99638166 |
| 85 | MP0002166_altered_tumor_susceptibility | 0.99159638 |
| 86 | MP0002420_abnormal_adaptive_immunity | 0.98782058 |
| 87 | MP0001819_abnormal_immune_cell | 0.98706457 |
| 88 | MP0008469_abnormal_protein_level | 0.98511140 |
| 89 | MP0003795_abnormal_bone_structure | 0.97843568 |
| 90 | MP0000598_abnormal_liver_morphology | 0.97784489 |
| 91 | MP0005464_abnormal_platelet_physiology | 0.96944339 |
| 92 | MP0008004_abnormal_stomach_pH | 0.95428096 |
| 93 | MP0005397_hematopoietic_system_phenotyp | 0.94670190 |
| 94 | MP0001545_abnormal_hematopoietic_system | 0.94670190 |
| 95 | MP0005165_increased_susceptibility_to | 0.94339872 |
| 96 | MP0004947_skin_inflammation | 0.93290599 |
| 97 | MP0009764_decreased_sensitivity_to | 0.92601545 |
| 98 | MP0004883_abnormal_blood_vessel | 0.92355518 |
| 99 | MP0002405_respiratory_system_inflammati | 0.92057347 |
| 100 | MP0000767_abnormal_smooth_muscle | 0.91236702 |
| 101 | MP0000920_abnormal_myelination | 0.91080790 |
| 102 | MP0001851_eye_inflammation | 0.91030335 |
| 103 | MP0002928_abnormal_bile_duct | 0.89615114 |
| 104 | MP0000013_abnormal_adipose_tissue | 0.89614801 |
| 105 | MP0002933_joint_inflammation | 0.89134668 |
| 106 | MP0001853_heart_inflammation | 0.88822609 |
| 107 | MP0000681_abnormal_thyroid_gland | 0.88820154 |
| 108 | MP0009642_abnormal_blood_homeostasis | 0.88759873 |
| 109 | MP0003690_abnormal_glial_cell | 0.88662203 |
| 110 | MP0001800_abnormal_humoral_immune | 0.88076483 |
| 111 | MP0000678_abnormal_parathyroid_gland | 0.87788876 |
| 112 | MP0005167_abnormal_blood-brain_barrier | 0.87685426 |
| 113 | MP0009384_cardiac_valve_regurgitation | 0.86865923 |
| 114 | MP0005503_abnormal_tendon_morphology | 0.86467105 |
| 115 | MP0003045_fibrosis | 0.85952050 |
| 116 | MP0005670_abnormal_white_adipose | 0.84512082 |
| 117 | MP0002822_catalepsy | 0.84026883 |
| 118 | MP0004264_abnormal_extraembryonic_tissu | 0.83766172 |
| 119 | MP0009333_abnormal_splenocyte_physiolog | 0.83041988 |
| 120 | MP0002796_impaired_skin_barrier | 0.82923193 |
| 121 | MP0001915_intracranial_hemorrhage | 0.82421975 |
| 122 | MP0000465_gastrointestinal_hemorrhage | 0.82244787 |
| 123 | MP0003634_abnormal_glial_cell | 0.81818112 |
| 124 | MP0002136_abnormal_kidney_physiology | 0.81607697 |
| 125 | MP0001533_abnormal_skeleton_physiology | 0.80171425 |
| 126 | MP0004808_abnormal_hematopoietic_stem | 0.78971913 |
| 127 | MP0001764_abnormal_homeostasis | 0.78116811 |
| 128 | MP0000249_abnormal_blood_vessel | 0.77854789 |
| 129 | MP0009763_increased_sensitivity_to | 0.77568976 |
| 130 | MP0005334_abnormal_fat_pad | 0.77545702 |
| 131 | MP0005535_abnormal_body_temperature | 0.77430603 |
| 132 | MP0006082_CNS_inflammation | 0.76760241 |
| 133 | MP0005671_abnormal_response_to | 0.76661382 |
| 134 | MP0001845_abnormal_inflammatory_respons | 0.76449874 |
| 135 | MP0005310_abnormal_salivary_gland | 0.75937141 |
| 136 | MP0005448_abnormal_energy_balance | 0.74720514 |
| 137 | MP0002896_abnormal_bone_mineralization | 0.73599071 |
| 138 | MP0003724_increased_susceptibility_to | 0.71626234 |
| 139 | MP0003566_abnormal_cell_adhesion | 0.70830662 |
| 140 | MP0004185_abnormal_adipocyte_glucose | 0.70307133 |
| 141 | MP0002168_other_aberrant_phenotype | 0.70090330 |
| 142 | MP0000639_abnormal_adrenal_gland | 0.69611536 |
| 143 | MP0005166_decreased_susceptibility_to | 0.68978697 |
| 144 | MP0001873_stomach_inflammation | 0.68784787 |
| 145 | MP0003638_abnormal_response/metabolism_ | 0.68319678 |
| 146 | MP0005666_abnormal_adipose_tissue | 0.68293782 |
| 147 | MP0005084_abnormal_gallbladder_morpholo | 0.67540917 |
| 148 | MP0000685_abnormal_immune_system | 0.67264450 |
| 149 | MP0003866_abnormal_defecation | 0.67115555 |
| 150 | MP0002971_abnormal_brown_adipose | 0.66819434 |
| 151 | MP0005451_abnormal_body_composition | 0.66260426 |
| 152 | MP0003959_abnormal_lean_body | 0.65487611 |
| 153 | MP0000003_abnormal_adipose_tissue | 0.65392866 |
| 154 | MP0003953_abnormal_hormone_level | 0.64466307 |
| 155 | MP0010368_abnormal_lymphatic_system | 0.64460415 |
| 156 | MP0005375_adipose_tissue_phenotype | 0.64428459 |
| 157 | MP0009765_abnormal_xenobiotic_induced | 0.63209417 |
| 158 | MP0005647_abnormal_sex_gland | 0.62990120 |
| 159 | MP0002419_abnormal_innate_immunity | 0.62512894 |
| 160 | MP0006054_spinal_hemorrhage | 0.60858278 |
| 161 | MP0001790_abnormal_immune_system | 0.59444552 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 5.32205745 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.85975696 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 4.63750547 |
| 4 | Xanthomatosis (HP:0000991) | 4.52398261 |
| 5 | Complement deficiency (HP:0004431) | 4.43036440 |
| 6 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.36718197 |
| 7 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.36718197 |
| 8 | Abnormality of glycolipid metabolism (HP:0010969) | 4.36718197 |
| 9 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.29968718 |
| 10 | Protrusio acetabuli (HP:0003179) | 3.97613032 |
| 11 | Premature rupture of membranes (HP:0001788) | 3.94042848 |
| 12 | Abnormality of the common coagulation pathway (HP:0010990) | 3.88066852 |
| 13 | Prolonged partial thromboplastin time (HP:0003645) | 3.76151019 |
| 14 | Vertebral compression fractures (HP:0002953) | 3.57222616 |
| 15 | Ketosis (HP:0001946) | 3.55082577 |
| 16 | Hyperlipoproteinemia (HP:0010980) | 3.44058917 |
| 17 | Hypoglycemic coma (HP:0001325) | 3.43613523 |
| 18 | Abnormality of complement system (HP:0005339) | 3.39340103 |
| 19 | Abnormality of the intrinsic pathway (HP:0010989) | 3.38003747 |
| 20 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.29624566 |
| 21 | Hypobetalipoproteinemia (HP:0003563) | 3.25371598 |
| 22 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.25058829 |
| 23 | Mucopolysacchariduria (HP:0008155) | 3.25058829 |
| 24 | Ketoacidosis (HP:0001993) | 3.22396999 |
| 25 | Systemic lupus erythematosus (HP:0002725) | 3.19491297 |
| 26 | Dysostosis multiplex (HP:0000943) | 3.14818009 |
| 27 | Joint hemorrhage (HP:0005261) | 3.13492596 |
| 28 | Fat malabsorption (HP:0002630) | 3.12958681 |
| 29 | Eczematoid dermatitis (HP:0000976) | 3.05160151 |
| 30 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.02660355 |
| 31 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.02660355 |
| 32 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.02660355 |
| 33 | Myocardial infarction (HP:0001658) | 2.98632531 |
| 34 | Abnormality of macrophages (HP:0004311) | 2.93699510 |
| 35 | Epidermoid cyst (HP:0200040) | 2.87108781 |
| 36 | Hyperammonemia (HP:0001987) | 2.86412600 |
| 37 | Hypoalphalipoproteinemia (HP:0003233) | 2.82011976 |
| 38 | Conjugated hyperbilirubinemia (HP:0002908) | 2.80872077 |
| 39 | Hypolipoproteinemia (HP:0010981) | 2.78562265 |
| 40 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.75878859 |
| 41 | Hypoglycemic seizures (HP:0002173) | 2.69733686 |
| 42 | Loss of speech (HP:0002371) | 2.63566395 |
| 43 | Gout (HP:0001997) | 2.62990726 |
| 44 | Glomerulonephritis (HP:0000099) | 2.62198860 |
| 45 | Vacuolated lymphocytes (HP:0001922) | 2.60125159 |
| 46 | Abnormality of purine metabolism (HP:0004352) | 2.59986722 |
| 47 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.53790498 |
| 48 | Hyperglycinuria (HP:0003108) | 2.53040644 |
| 49 | Skin nodule (HP:0200036) | 2.50042499 |
| 50 | Late onset (HP:0003584) | 2.49726295 |
| 51 | Mitral stenosis (HP:0001718) | 2.48098664 |
| 52 | Cervical subluxation (HP:0003308) | 2.44260431 |
| 53 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.42175440 |
| 54 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.41159799 |
| 55 | Hypercholesterolemia (HP:0003124) | 2.40246917 |
| 56 | Arterial tortuosity (HP:0005116) | 2.39643974 |
| 57 | Aortic dissection (HP:0002647) | 2.38155648 |
| 58 | Vascular tortuosity (HP:0004948) | 2.37324772 |
| 59 | Atrophic scars (HP:0001075) | 2.36446956 |
| 60 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.36035451 |
| 61 | Abnormality of glycine metabolism (HP:0010895) | 2.36035451 |
| 62 | Thin bony cortex (HP:0002753) | 2.36026618 |
| 63 | Recurrent abscess formation (HP:0002722) | 2.35369506 |
| 64 | Hyperglycinemia (HP:0002154) | 2.32321373 |
| 65 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.31637033 |
| 66 | Amyloidosis (HP:0011034) | 2.30427520 |
| 67 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.28214673 |
| 68 | Spondylolisthesis (HP:0003302) | 2.25583487 |
| 69 | Steatorrhea (HP:0002570) | 2.24938552 |
| 70 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.21379431 |
| 71 | Sensorimotor neuropathy (HP:0007141) | 2.19373800 |
| 72 | Hepatocellular carcinoma (HP:0001402) | 2.16858211 |
| 73 | Abnormality of proline metabolism (HP:0010907) | 2.16722283 |
| 74 | Hydroxyprolinuria (HP:0003080) | 2.16722283 |
| 75 | Nuclear cataract (HP:0100018) | 2.15568518 |
| 76 | Menorrhagia (HP:0000132) | 2.15121251 |
| 77 | Purpura (HP:0000979) | 2.14172119 |
| 78 | Hyperbilirubinemia (HP:0002904) | 2.13870483 |
| 79 | Blue sclerae (HP:0000592) | 2.13192713 |
| 80 | Abnormality of nucleobase metabolism (HP:0010932) | 2.12977192 |
| 81 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.12542642 |
| 82 | Esophageal varix (HP:0002040) | 2.11781432 |
| 83 | Recurrent bacterial skin infections (HP:0005406) | 2.11680696 |
| 84 | Protuberant abdomen (HP:0001538) | 2.08756217 |
| 85 | J-shaped sella turcica (HP:0002680) | 2.08319651 |
| 86 | Myositis (HP:0100614) | 2.07857227 |
| 87 | Nephritis (HP:0000123) | 2.07613043 |
| 88 | Hyperglycemia (HP:0003074) | 2.05932067 |
| 89 | Wormian bones (HP:0002645) | 2.04957197 |
| 90 | Pancreatitis (HP:0001733) | 2.03829395 |
| 91 | Gingivitis (HP:0000230) | 2.03365019 |
| 92 | Dilatation of the ascending aorta (HP:0005111) | 2.03314093 |
| 93 | Vascular calcification (HP:0004934) | 1.99692159 |
| 94 | Symptomatic seizures (HP:0011145) | 1.97953127 |
| 95 | Fragile skin (HP:0001030) | 1.96666655 |
| 96 | Hyperacusis (HP:0010780) | 1.96617413 |
| 97 | Orchitis (HP:0100796) | 1.94642470 |
| 98 | Bone pain (HP:0002653) | 1.93521621 |
| 99 | Cellulitis (HP:0100658) | 1.93242256 |
| 100 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.93062127 |
| 101 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.93062127 |
| 102 | Bladder diverticulum (HP:0000015) | 1.92937194 |
| 103 | Thoracic kyphosis (HP:0002942) | 1.91932722 |
| 104 | Pathologic fracture (HP:0002756) | 1.91774883 |
| 105 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.91489902 |
| 106 | Osteolytic defects of the hand bones (HP:0009699) | 1.91489902 |
| 107 | Gingival bleeding (HP:0000225) | 1.90385978 |
| 108 | Flat acetabular roof (HP:0003180) | 1.90024896 |
| 109 | Asymmetric septal hypertrophy (HP:0001670) | 1.89030877 |
| 110 | Cardiovascular calcification (HP:0011915) | 1.88868363 |
| 111 | Cerebral aneurysm (HP:0004944) | 1.88226227 |
| 112 | Increased CSF protein (HP:0002922) | 1.86877715 |
| 113 | Increased variability in muscle fiber diameter (HP:0003557) | 1.86580365 |
| 114 | Increased cerebral lipofuscin (HP:0011813) | 1.86456278 |
| 115 | Abnormality of dentin (HP:0010299) | 1.85647536 |
| 116 | Retinal atrophy (HP:0001105) | 1.84676066 |
| 117 | Abdominal distention (HP:0003270) | 1.84539225 |
| 118 | Spastic diplegia (HP:0001264) | 1.83973884 |
| 119 | Biconcave vertebral bodies (HP:0004586) | 1.83879575 |
| 120 | Neurofibrillary tangles (HP:0002185) | 1.83427751 |
| 121 | Abnormality of the thoracic spine (HP:0100711) | 1.83358361 |
| 122 | Abnormality of methionine metabolism (HP:0010901) | 1.82363584 |
| 123 | Upper limb amyotrophy (HP:0009129) | 1.82361863 |
| 124 | Distal upper limb amyotrophy (HP:0007149) | 1.82361863 |
| 125 | Achilles tendon contracture (HP:0001771) | 1.81708718 |
| 126 | Abnormal cartilage morphology (HP:0002763) | 1.81129021 |
| 127 | Axonal loss (HP:0003447) | 1.81056735 |
| 128 | Back pain (HP:0003418) | 1.78950496 |
| 129 | Hemorrhage of the eye (HP:0011885) | 1.78931140 |
| 130 | Turricephaly (HP:0000262) | 1.78883958 |
| 131 | Global brain atrophy (HP:0002283) | 1.78669515 |
| 132 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.78027906 |
| 133 | Malnutrition (HP:0004395) | 1.77817415 |
| 134 | Neonatal onset (HP:0003623) | 1.77753196 |
| 135 | Cerebral inclusion bodies (HP:0100314) | 1.77080382 |
| 136 | Increased connective tissue (HP:0009025) | 1.77070019 |
| 137 | Broad face (HP:0000283) | 1.76421053 |
| 138 | Peritonitis (HP:0002586) | 1.74768727 |
| 139 | Aortic aneurysm (HP:0004942) | 1.74228065 |
| 140 | Irritability (HP:0000737) | 1.74038595 |
| 141 | Joint stiffness (HP:0001387) | 1.73638288 |
| 142 | Polygenic inheritance (HP:0010982) | 1.73544581 |
| 143 | Stroke (HP:0001297) | 1.72135284 |
| 144 | Genu recurvatum (HP:0002816) | 1.71475588 |
| 145 | Spontaneous hematomas (HP:0007420) | 1.71211629 |
| 146 | Polycythemia (HP:0001901) | 1.70661805 |
| 147 | Upper motor neuron abnormality (HP:0002127) | 1.70341775 |
| 148 | Neuronal loss in central nervous system (HP:0002529) | 1.69442527 |
| 149 | Elevated alkaline phosphatase (HP:0003155) | 1.68120449 |
| 150 | Delayed CNS myelination (HP:0002188) | 1.68067767 |
| 151 | Abnormality of the Achilles tendon (HP:0005109) | 1.68029187 |
| 152 | Generalized aminoaciduria (HP:0002909) | 1.67998557 |
| 153 | Cardiomegaly (HP:0001640) | 1.67575231 |
| 154 | Hyperparathyroidism (HP:0000843) | 1.66976121 |
| 155 | Distal lower limb muscle weakness (HP:0009053) | 1.66745558 |
| 156 | Colitis (HP:0002583) | 1.66644252 |
| 157 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.65967117 |
| 158 | Metabolic acidosis (HP:0001942) | 1.65775010 |
| 159 | Supranuclear gaze palsy (HP:0000605) | 1.65765323 |
| 160 | Interstitial pulmonary disease (HP:0006530) | 1.65099518 |
| 161 | Aneurysm (HP:0002617) | 1.64940614 |
| 162 | Apathy (HP:0000741) | 1.63467830 |
| 163 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.63198073 |
| 164 | Short nail (HP:0001799) | 1.62971476 |
| 165 | Coxa vara (HP:0002812) | 1.62632038 |
| 166 | Abnormality of the peritoneum (HP:0002585) | 1.62552462 |
| 167 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.62202822 |
| 168 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 1.62052702 |
| 169 | Diminished motivation (HP:0000745) | 1.61481489 |
| 170 | Mitral regurgitation (HP:0001653) | 1.61248937 |
| 171 | Ulnar bowing (HP:0003031) | 1.61135186 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 4.41386486 |
| 2 | TRIB3 | 3.86728256 |
| 3 | TAOK3 | 3.49497025 |
| 4 | SIK1 | 3.03619236 |
| 5 | BCKDK | 2.88746772 |
| 6 | FGFR4 | 2.77184640 |
| 7 | PKN2 | 2.75685798 |
| 8 | PRPF4B | 2.53409478 |
| 9 | INSRR | 2.34531492 |
| 10 | MST1R | 2.22403390 |
| 11 | PTK6 | 2.12463066 |
| 12 | FRK | 2.01900841 |
| 13 | EPHB1 | 1.98354153 |
| 14 | SMG1 | 1.84821232 |
| 15 | EEF2K | 1.73167484 |
| 16 | RIPK1 | 1.72323832 |
| 17 | RIPK4 | 1.54747993 |
| 18 | YES1 | 1.53934974 |
| 19 | JAK1 | 1.53896446 |
| 20 | TESK1 | 1.50730635 |
| 21 | MOS | 1.49531965 |
| 22 | TYK2 | 1.49344862 |
| 23 | NME2 | 1.48118249 |
| 24 | PDGFRA | 1.44929283 |
| 25 | EPHA2 | 1.41476698 |
| 26 | PAK4 | 1.40884682 |
| 27 | CDC42BPA | 1.37236455 |
| 28 | FLT3 | 1.35774859 |
| 29 | TESK2 | 1.32838493 |
| 30 | MAPK15 | 1.29954006 |
| 31 | CDK12 | 1.29329024 |
| 32 | TBK1 | 1.28309624 |
| 33 | TGFBR2 | 1.28109577 |
| 34 | MAP3K11 | 1.25083813 |
| 35 | JAK2 | 1.19139297 |
| 36 | MAP3K10 | 1.19088450 |
| 37 | MAP3K2 | 1.18034591 |
| 38 | RET | 1.17719901 |
| 39 | PRKCH | 1.16702473 |
| 40 | CAMK1D | 1.13727533 |
| 41 | FGFR3 | 1.10142703 |
| 42 | SCYL2 | 1.08829156 |
| 43 | PIK3CG | 1.08533325 |
| 44 | LRRK2 | 1.07036040 |
| 45 | PTK2 | 1.06750172 |
| 46 | CAMK1G | 1.06261278 |
| 47 | IRAK4 | 1.05281465 |
| 48 | TAOK2 | 1.05227898 |
| 49 | NTRK1 | 1.04397780 |
| 50 | EPHA3 | 1.03159643 |
| 51 | MAP4K1 | 1.01981353 |
| 52 | MAP3K1 | 1.00818485 |
| 53 | DAPK2 | 1.00354393 |
| 54 | FGFR2 | 0.99385238 |
| 55 | CAMKK1 | 0.96577920 |
| 56 | MARK2 | 0.95998792 |
| 57 | CSK | 0.93837429 |
| 58 | ZAP70 | 0.90576150 |
| 59 | FGR | 0.90401555 |
| 60 | MAP2K2 | 0.88542888 |
| 61 | ARAF | 0.87358243 |
| 62 | MET | 0.86052936 |
| 63 | WNK4 | 0.85923629 |
| 64 | MAP3K7 | 0.85752584 |
| 65 | HIPK2 | 0.85104738 |
| 66 | GRK6 | 0.84234370 |
| 67 | LATS2 | 0.83920837 |
| 68 | KSR2 | 0.82774994 |
| 69 | DYRK1B | 0.78986180 |
| 70 | PIM2 | 0.77738691 |
| 71 | JAK3 | 0.76356517 |
| 72 | LATS1 | 0.76213503 |
| 73 | ITK | 0.75773797 |
| 74 | MAP3K6 | 0.74393703 |
| 75 | MAP3K13 | 0.73401061 |
| 76 | MAPK11 | 0.72427857 |
| 77 | EPHB2 | 0.72421446 |
| 78 | TAOK1 | 0.71889966 |
| 79 | PDGFRB | 0.71666794 |
| 80 | MATK | 0.71161071 |
| 81 | PDPK1 | 0.70934360 |
| 82 | CDK6 | 0.70433681 |
| 83 | FER | 0.69931743 |
| 84 | BMX | 0.68622841 |
| 85 | DDR2 | 0.65987141 |
| 86 | IRAK3 | 0.64693422 |
| 87 | KIT | 0.62835291 |
| 88 | IKBKE | 0.61689364 |
| 89 | CSF1R | 0.61481928 |
| 90 | PRKD3 | 0.61261522 |
| 91 | FES | 0.59961727 |
| 92 | MAP2K4 | 0.58969070 |
| 93 | SIK3 | 0.58426428 |
| 94 | CAMKK2 | 0.57172815 |
| 95 | MAPKAPK2 | 0.56030422 |
| 96 | SIK2 | 0.55729409 |
| 97 | PDK1 | 0.55350590 |
| 98 | MAPKAPK3 | 0.54752875 |
| 99 | RPS6KL1 | 0.54071326 |
| 100 | RPS6KC1 | 0.54071326 |
| 101 | LMTK2 | 0.53863733 |
| 102 | NEK9 | 0.53691507 |
| 103 | STK38 | 0.53681412 |
| 104 | PRKD1 | 0.52056132 |
| 105 | TTN | 0.51499414 |
| 106 | BLK | 0.51145811 |
| 107 | ERBB4 | 0.50835319 |
| 108 | PRKG2 | 0.50005566 |
| 109 | GSK3A | 0.49247661 |
| 110 | SGK3 | 0.49133686 |
| 111 | MAP2K3 | 0.47554266 |
| 112 | STK10 | 0.47512051 |
| 113 | IRAK2 | 0.47437873 |
| 114 | MAP3K3 | 0.47358155 |
| 115 | RPS6KA2 | 0.46843603 |
| 116 | PRKAA2 | 0.46307603 |
| 117 | MAP2K1 | 0.46097087 |
| 118 | PAK3 | 0.46043095 |
| 119 | MAPK7 | 0.45902578 |
| 120 | ABL2 | 0.45598115 |
| 121 | HCK | 0.44961758 |
| 122 | LYN | 0.44719293 |
| 123 | MAP3K9 | 0.42932486 |
| 124 | PRKD2 | 0.42836361 |
| 125 | MTOR | 0.42049295 |
| 126 | BTK | 0.41723214 |
| 127 | MAP3K14 | 0.41534402 |
| 128 | IGF1R | 0.40271702 |
| 129 | TRPM7 | 0.40054951 |
| 130 | EGFR | 0.39395988 |
| 131 | PRKCZ | 0.38894928 |
| 132 | ICK | 0.38493890 |
| 133 | MAP3K8 | 0.38418809 |
| 134 | KDR | 0.36977087 |
| 135 | PAK2 | 0.36008798 |
| 136 | PRKAA1 | 0.35876167 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.47967859 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.40223870 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.84836312 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.61612328 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.53081406 |
| 6 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.34382246 |
| 7 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.32252185 |
| 8 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.31747085 |
| 9 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.20106727 |
| 10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.17446855 |
| 11 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.13384926 |
| 12 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.94572923 |
| 13 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.92019386 |
| 14 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.87868655 |
| 15 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.83394186 |
| 16 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.75661552 |
| 17 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.72368451 |
| 18 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.69769949 |
| 19 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.66368087 |
| 20 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.65741918 |
| 21 | Bile secretion_Homo sapiens_hsa04976 | 1.63065142 |
| 22 | Leishmaniasis_Homo sapiens_hsa05140 | 1.58970818 |
| 23 | Histidine metabolism_Homo sapiens_hsa00340 | 1.53305701 |
| 24 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.49940063 |
| 25 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.48292860 |
| 26 | Peroxisome_Homo sapiens_hsa04146 | 1.46366863 |
| 27 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.44864063 |
| 28 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.44505746 |
| 29 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.40770478 |
| 30 | ABC transporters_Homo sapiens_hsa02010 | 1.38149600 |
| 31 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.37083849 |
| 32 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.36298240 |
| 33 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.33986331 |
| 34 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.33151357 |
| 35 | Malaria_Homo sapiens_hsa05144 | 1.31823596 |
| 36 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.30879585 |
| 37 | Phagosome_Homo sapiens_hsa04145 | 1.28980878 |
| 38 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.28874151 |
| 39 | Tuberculosis_Homo sapiens_hsa05152 | 1.26931827 |
| 40 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.25912465 |
| 41 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.25204099 |
| 42 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.24835735 |
| 43 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.21879748 |
| 44 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.20983177 |
| 45 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.17813626 |
| 46 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.15614880 |
| 47 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.15236912 |
| 48 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.14075270 |
| 49 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.13695524 |
| 50 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.13129624 |
| 51 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.11899177 |
| 52 | Salmonella infection_Homo sapiens_hsa05132 | 1.09242246 |
| 53 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.07845113 |
| 54 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.07791621 |
| 55 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.05932369 |
| 56 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.04166358 |
| 57 | Lysosome_Homo sapiens_hsa04142 | 1.01583673 |
| 58 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.00081114 |
| 59 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.99715349 |
| 60 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.99130246 |
| 61 | Other glycan degradation_Homo sapiens_hsa00511 | 0.98369008 |
| 62 | Influenza A_Homo sapiens_hsa05164 | 0.97290327 |
| 63 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.97134021 |
| 64 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.96885275 |
| 65 | * Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.96587575 |
| 66 | Sulfur relay system_Homo sapiens_hsa04122 | 0.96048534 |
| 67 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.90836472 |
| 68 | Hepatitis B_Homo sapiens_hsa05161 | 0.90458923 |
| 69 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.90097106 |
| 70 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.89847146 |
| 71 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.89706776 |
| 72 | Focal adhesion_Homo sapiens_hsa04510 | 0.87438286 |
| 73 | Apoptosis_Homo sapiens_hsa04210 | 0.86435134 |
| 74 | Retinol metabolism_Homo sapiens_hsa00830 | 0.85766918 |
| 75 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.85669742 |
| 76 | Lysine degradation_Homo sapiens_hsa00310 | 0.84556968 |
| 77 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.84280870 |
| 78 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.83626920 |
| 79 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.82860943 |
| 80 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.82306896 |
| 81 | Shigellosis_Homo sapiens_hsa05131 | 0.82169588 |
| 82 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.81704618 |
| 83 | Viral myocarditis_Homo sapiens_hsa05416 | 0.81576590 |
| 84 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.81268620 |
| 85 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.80916469 |
| 86 | Allograft rejection_Homo sapiens_hsa05330 | 0.80229299 |
| 87 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.80156738 |
| 88 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.78794243 |
| 89 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.78408938 |
| 90 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.77764812 |
| 91 | Measles_Homo sapiens_hsa05162 | 0.77658179 |
| 92 | Endocytosis_Homo sapiens_hsa04144 | 0.76363687 |
| 93 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.75725012 |
| 94 | Insulin resistance_Homo sapiens_hsa04931 | 0.75310829 |
| 95 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.73606156 |
| 96 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.72889593 |
| 97 | Prion diseases_Homo sapiens_hsa05020 | 0.72696396 |
| 98 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.71851966 |
| 99 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.70603221 |
| 100 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.70385845 |
| 101 | Endometrial cancer_Homo sapiens_hsa05213 | 0.70310142 |
| 102 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.69860416 |
| 103 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.69433202 |
| 104 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.69296176 |
| 105 | Glioma_Homo sapiens_hsa05214 | 0.69186606 |
| 106 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.67754916 |
| 107 | Legionellosis_Homo sapiens_hsa05134 | 0.67431831 |
| 108 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.66384137 |
| 109 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.65773714 |
| 110 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.64838361 |
| 111 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.64102340 |
| 112 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.62603649 |
| 113 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.61919744 |
| 114 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.61832612 |
| 115 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.61682047 |
| 116 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.61667059 |
| 117 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.61624790 |
| 118 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.60471474 |
| 119 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.60429300 |
| 120 | Thyroid cancer_Homo sapiens_hsa05216 | 0.60401146 |
| 121 | Platelet activation_Homo sapiens_hsa04611 | 0.59032577 |
| 122 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.58389229 |
| 123 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.58233734 |
| 124 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.57472386 |
| 125 | Carbon metabolism_Homo sapiens_hsa01200 | 0.57411947 |
| 126 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.57278151 |
| 127 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.56995826 |
| 128 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.54647248 |
| 129 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.54314963 |
| 130 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.54200568 |
| 131 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.53547997 |
| 132 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.53532914 |
| 133 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.53359420 |
| 134 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.52031962 |
| 135 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.51260452 |
| 136 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.50949055 |
| 137 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.50166659 |
| 138 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.49777638 |
| 139 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.48705550 |
| 140 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.48398235 |
| 141 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.46089429 |
| 142 | Galactose metabolism_Homo sapiens_hsa00052 | 0.42273603 |
| 143 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.40207087 |
| 144 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.40159146 |
| 145 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.38111824 |
| 146 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.36901468 |
| 147 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.35116935 |
| 148 | Insulin secretion_Homo sapiens_hsa04911 | 0.32262245 |
| 149 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.31649071 |
| 150 | Amoebiasis_Homo sapiens_hsa05146 | 0.31118560 |
| 151 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.30726719 |
| 152 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.28388723 |
| 153 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.27369780 |
| 154 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.24729289 |
| 155 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.23541963 |
| 156 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.21318801 |
| 157 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.21188723 |
| 158 | Pertussis_Homo sapiens_hsa05133 | 0.21151358 |
| 159 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.20806783 |
| 160 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.20773831 |
| 161 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.19677051 |
| 162 | Bladder cancer_Homo sapiens_hsa05219 | 0.19544619 |
| 163 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.19466213 |
| 164 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.19218542 |
| 165 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.17812410 |
| 166 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.16777143 |
| 167 | Hepatitis C_Homo sapiens_hsa05160 | 0.16164452 |
| 168 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.15260513 |
| 169 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.14687174 |
| 170 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.14248375 |

